CYCN
NASDAQ · Biotechnology
Cyclerion Therapeutics Inc
$34.98
+1.77 (+5.33%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
-37.8% upside
Low Target
$14.42
Average Target
$21.77
High Target
$30.48
Current Price
$34.98
Current
$34.98
$34.98
Target
$21.77
$21.77
$14.42
$21.77 avg
$30.48
Scenario Analysis
Bear Case
$14.42
-58.8%
Low target
Base Case
$21.77
-37.8%
Avg target
Bull Case
$30.48
+-12.9%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$59.36
-41.1% from high
52-Week Low
$7.19
+386.5% from low
Target vs 52W High
$21.77
-63.3% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -3.3% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.4% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +138.3% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.9% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.3% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.4% |